CLINICAL_TRIALS
trial_result
· 2018-10-15
Clinical Trial Update: Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial [Phase 4]
Summary
A double-blind randomized placebo-controlled Phase 4 trial evaluating kava for generalized anxiety disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Melbourne | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED